NEWS ABOUT THE CURE

Translating Clinical Trials

Keith Desserich, Chairman of the Board at The Cure Starts Now, explains clinical trials – what they mean for cancer patients and how they work. Clinical trials are set up in phases, all designed to focus on an idea. We call these preclinical, or even translational research trials. They are designed to conduct testing on cancer cells in a test tube or mouse modeling.  Ultimately you are trying to determine whether or not this idea, this concept, is actually going to work on cancer cells. From

Cancer Research Fundraiser Goes Global & Exceeds Expectations by 700% Despite COVID-19

The Cure Starts Now’s "The Great Relay for Research" Raised Over $175,000 for Homerun Cure™ Cancer Research Cincinnati, OH | October 1, 2020 — The Cure Starts Now’s first annual “The Great Relay for Research” raised $179,105 for Homerun Cure™ cancer research surpassing their original goal by over 700 percent. With the cancellation of nearly 120 crucial spring and summer fundraising events due to the ongoing COVID-19 pandemic, the cancer research grant funding cycle for The Cure Starts Now is in

Research Update: Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to DIPG

In 2017 Dr. Mara Vinci of the Bambino Gesù Children’s Hospital proposed an innovative study into investigating the role of DIPG-derived exosomes in tumor growth and invasion. This project was approved for funding by the DIPG/DMG Collaborative and The Cure Starts Now and here are his results: Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG Abstract The intratumor heterogeneity represents one of the most difficult challeng

Cincinnati Children's Announces Naming of Brain Tumor Center

The following article first appeared on cincinnatichildrens.org: Brain Tumor Center to be named after foundation that helps fight pediatric brain cancers Cincinnati Children’s Hospital Medical Center and The Cure Starts Now Foundation have been working together for more than 12 years to find ways to cure pediatric cancers. To recognize the collaboration, Cincinnati Children’s is announcing the naming of The Cure Starts Now Foundation Brain Tumor Center as part of a multimillion-dollar donatio

Graeter's Annual Cones for the Cure Campaign Raises Over $1 Million

Cones For The Cure Fundraising Campaign Has Raised Over $1 Million For Homerun Cure™ Cancer Research Since It Began In 2009 Cincinnati, OH | September 11, 2020 — The Cure Starts Now, in partnership with Graeter’s, today announced that the Cones for the Cure campaign has raised over $1 million in funds for Homerun Cure™ cancer research since its inception in 2009. The Cure Starts Now and Graeter’s have teamed up for the past 11 years to raise funds for crucial cancer research through the Cones

Dr. Han Shen Discusses Overall Progress on his DIPG Research for The Cure Starts Now and the DIPG Collaborative

Dr. Han Shen, Westmead Institute for Medical Research, AustraliaFunded Project: Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomasFunded Amount: $100,000 Dr. Shen provides an update on his recent project with the DIPG Collaborative and The Cure Starts Now and explains how it is providing clues to new treatment options for diffuse instrinsic pontine glioma. "DIPG is the most malignant childhood prim

Research Update: New Links to Overcome Radiation Resistance in High-Grade Gliomas

In 2019 Dr. Han Shen of the University of Sydney  proposed an innovative study into the impact of glycolysis, hypoxia, and circadian rhythm on radiotherapy treatment to high grade gliomas. Its impact would be to possibly refine how we administer radiation to patients in the hopes of improving one of the oldest and most effective treatments to brain cancers. This project was approved for funding by the DIPG/DMG Collaborative and The Cure Starts Now and here are his results: Hypoxia, metabolism, a

Chris Jones: Beyond the Lab

Team Leader at The Institute of Cancer Research The Cure Starts Now recently sat down and had a conversation with leading DIPG researcher, Dr. Chris Jones: Why did you decide to focus your research on DIPG/DMG?"When I started my lab, the remit was to develop a research program in an area of unmet need in childhood cancer – nothing exemplifies this better than DIPG/DMG." What are some of the greatest advancements you have seen with DIPG/DMG research?"What is most remarkable is the way the intern

Getting Involved in the Fight Against DIPG and DMG

Want to talk today a little bit about getting involved. Not a day goes by that we don't get an email from a parent or a patient, and they want to know what they can do to help out with DIPG and DMG causes. There’re many ways that people can get involved, but I wanted to talk about a few of them here today. So that in the hopes that more people can get involved in this fight, more people can help us win this fight and more people can join us in this collaborative effort. Because it's really go

The Value of Data and the International DIPG/DMG Registry

The following article originally appeared on DIPG.org Data by itself offers us no clues to beating cancer. Even as a result of diligent collection from a research trial it offers little more than a confirmation of hypothesis. But what happens when data gets together? What happens when you collect data organically, across platforms and at the source? There you can detect patterns, form new theories and even cure cancer. It’s not a novel idea to collect data. For hundreds of years researchers fig